Lidocaine transdermal--Vyteris.
D000279:Administration, Cutaneous; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D016503:Drug Delivery Systems; D006801:Humans; D007267:Injections / Q000009:adverse effects; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D010146:Pain / Q000517:prevention & control*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
D000779:Anesthetics, Local; D008012:Lidocaine